DiNuzzo Private Wealth »

Vertex Pharmaceuticals Incorporated shares owned by DiNuzzo Private Wealth

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by DiNuzzo Private Wealth from 13F filings

Historical chart of DiNuzzo Private Wealth investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by DiNuzzo Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by DiNuzzo Private Wealth

Quarter filed Position value Share count Share price at filing
2024-09-30 $13k 27 465.11
2024-06-30 $13k 27 468.74
2024-03-31 $6.7k 16 418.06
2023-12-31 $6.9k 17 406.94

More positions owned by DiNuzzo Private Wealth

Dimensional Etf Trust Short Duration F (DFSD)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Dimensional Etf Trust Global Real Est (DFGR)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Small Cap V (DISV)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Intl High Profit (DIHP)
Dimensional Etf Trust Global Cr Etf (DGCB)

View all positions for DiNuzzo Private Wealth

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Amundi
Morgan Stanley
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated